Gilead Sciences Inc (GILD)

Debt-to-assets ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Long-term debt US$ in thousands 23,189,000 23,189,000 21,209,000 22,956,000 22,957,000 22,953,000 25,195,000 25,183,000 25,179,000 25,175,000 27,914,000 27,907,000 28,645,000 27,792,000 21,103,000 22,098,000 22,094,000 22,090,000 24,084,000 24,080,000
Total assets US$ in thousands 62,125,000 62,373,000 62,337,000 61,876,000 63,171,000 62,557,000 62,870,000 63,080,000 67,952,000 67,098,000 67,984,000 67,492,000 68,407,000 60,878,000 55,934,000 59,741,000 61,627,000 59,146,000 63,210,000 62,837,000
Debt-to-assets ratio 0.37 0.37 0.34 0.37 0.36 0.37 0.40 0.40 0.37 0.38 0.41 0.41 0.42 0.46 0.38 0.37 0.36 0.37 0.38 0.38

December 31, 2023 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $23,189,000K ÷ $62,125,000K
= 0.37

The debt-to-assets ratio of Gilead Sciences, Inc. has been relatively stable around the range of 0.40 to 0.42 over the past eight quarters. This indicates that, on average, the company has been financing approximately 40% to 42% of its assets with debt during this period.

A debt-to-assets ratio of less than 1 suggests that Gilead Sciences has more assets than debt, which can be considered a positive sign as it indicates lower financial risk. However, the slight increase in the ratio from 0.40 in Q4 2022 to 0.42 in Q2 2022 and Q1 2022 could imply that the company has taken on slightly more debt relative to its assets in those quarters.

Overall, the consistent range of the debt-to-assets ratio around 0.40 to 0.42 indicates that Gilead Sciences has been maintaining a prudent balance between debt and assets in its capital structure, which is important for financial stability and long-term sustainability. Further analysis of the company's financial health and performance alongside other key financial ratios would provide a more comprehensive assessment.


Peer comparison

Dec 31, 2023


See also:

Gilead Sciences Inc Debt to Assets (Quarterly Data)